alanine has been researched along with Anasarca in 10 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 mmol each of phenylalanine, tryptophan, and tyrosine compared with isonitrogenous amounts of alanine (Ala) would improve measures of protein kinetics in 14 (8 with AAA, 6 Ala) children with edematous malnutrition (aged 6-24 mo) during the infected acute malnourished state." | 7.72 | Supplementation with aromatic amino acids improves leucine kinetics but not aromatic amino acid kinetics in infants with infection, severe malnutrition, and edema. ( Badaloo, A; Forrester, T; Heird, WC; Jahoor, F; Reid, M, 2004) |
| "Thirty-three ovine corticotropin-releasing factor (CRF) analogs, systematically substituted with alanine (Ala) residues, were tested for inhibitory activity on edema induced in the pentobarbital-anesthetized rat paw by heat (immersion in 58 degrees C water for 1 min)." | 7.69 | Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs. ( Thomas, HA; Wei, ET, 1994) |
| "C fiber dorsal root reflexes (DRR) contribute to neurogenic inflammation and possibly also to touch-evoked pain (allodynia) induced by intradermal capsaicin." | 3.73 | Response properties of dorsal root reflexes in cutaneous C fibers before and after intradermal capsaicin injection in rats. ( Dougherty, PM; Weng, HR, 2005) |
| "5 mmol each of phenylalanine, tryptophan, and tyrosine compared with isonitrogenous amounts of alanine (Ala) would improve measures of protein kinetics in 14 (8 with AAA, 6 Ala) children with edematous malnutrition (aged 6-24 mo) during the infected acute malnourished state." | 3.72 | Supplementation with aromatic amino acids improves leucine kinetics but not aromatic amino acid kinetics in infants with infection, severe malnutrition, and edema. ( Badaloo, A; Forrester, T; Heird, WC; Jahoor, F; Reid, M, 2004) |
| "Thirty-three ovine corticotropin-releasing factor (CRF) analogs, systematically substituted with alanine (Ala) residues, were tested for inhibitory activity on edema induced in the pentobarbital-anesthetized rat paw by heat (immersion in 58 degrees C water for 1 min)." | 3.69 | Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs. ( Thomas, HA; Wei, ET, 1994) |
| "Rebamipide (REB) a potent anti-ulcer agent, has not been exploited to its full potential, owing to it extremely poor solubility, leading to highly diminutive bioavailability (<10%)." | 1.62 | Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies. ( Chadha, R; Dureja, J; Jindal, A; Karan, M; Singh, R; Tomar, S, 2021) |
| " In rats, systemic and local findings were considered not adverse due to their low severity and reversibility; therefore, the "no observed adverse effect level" (NOAEL) was set at 1,000 μg/kg/day." | 1.62 | A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs. ( Alessi, T; Feldman, PL; Felx, M; Jain, R; Roller, S; Shelton, J; Singh, R; Wang, Y; Yang, B; Zane, D, 2021) |
| " The Fab' fragment of the antibody was therefore modified with polyethylene glycol (PEG) in order to obtain a more desirable pharmacokinetic profile." | 1.31 | Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation. ( Chen, H; Chuntharapai, A; DeForge, L; Deveney, J; Fan, A; Galan, W; Gonzalez, T; Gribling, P; Hale, V; Hébert, C; Hsei, V; Kim, KJ; Koumenis, I; Lee, WP; Leong, SR; McKay, P; Narindray, D; Presta, L; Reichert, M; Schoenhoff, M; Shahrokh, Z; Snedecor, B; Tumas, DB; Wagner, B; Zapata, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jindal, A | 1 |
| Singh, R | 2 |
| Tomar, S | 1 |
| Dureja, J | 1 |
| Karan, M | 1 |
| Chadha, R | 1 |
| Zane, D | 1 |
| Roller, S | 1 |
| Shelton, J | 1 |
| Jain, R | 1 |
| Wang, Y | 1 |
| Yang, B | 1 |
| Felx, M | 1 |
| Alessi, T | 1 |
| Feldman, PL | 1 |
| Festa, C | 1 |
| De Marino, S | 1 |
| Sepe, V | 1 |
| D'Auria, MV | 1 |
| Bifulco, G | 1 |
| Débitus, C | 1 |
| Bucci, M | 1 |
| Vellecco, V | 1 |
| Zampella, A | 1 |
| Lattanzi, R | 1 |
| Sacerdote, P | 1 |
| Franchi, S | 1 |
| Canestrelli, M | 1 |
| Miele, R | 1 |
| Barra, D | 1 |
| Visentin, S | 1 |
| DeNuccio, C | 1 |
| Porreca, F | 1 |
| De Felice, M | 1 |
| Guida, F | 1 |
| Luongo, L | 1 |
| de Novellis, V | 1 |
| Maione, S | 1 |
| Negri, L | 1 |
| Reid, M | 1 |
| Forrester, T | 1 |
| Badaloo, A | 1 |
| Heird, WC | 1 |
| Jahoor, F | 1 |
| Weng, HR | 1 |
| Dougherty, PM | 1 |
| Rincón, AC | 1 |
| Molina-Martinez, IT | 1 |
| de Las Heras, B | 1 |
| Alonso, M | 1 |
| Baílez, C | 1 |
| Rodríguez-Cabello, JC | 1 |
| Herrero-Vanrell, R | 1 |
| Burstein, SH | 1 |
| Adams, JK | 1 |
| Bradshaw, HB | 1 |
| Fraioli, C | 1 |
| Rossetti, RG | 1 |
| Salmonsen, RA | 1 |
| Shaw, JW | 1 |
| Walker, JM | 1 |
| Zipkin, RE | 1 |
| Zurier, RB | 1 |
| Wei, ET | 1 |
| Thomas, HA | 1 |
| Leong, SR | 1 |
| DeForge, L | 1 |
| Presta, L | 1 |
| Gonzalez, T | 1 |
| Fan, A | 1 |
| Reichert, M | 1 |
| Chuntharapai, A | 1 |
| Kim, KJ | 1 |
| Tumas, DB | 1 |
| Lee, WP | 1 |
| Gribling, P | 1 |
| Snedecor, B | 1 |
| Chen, H | 1 |
| Hsei, V | 1 |
| Schoenhoff, M | 1 |
| Hale, V | 1 |
| Deveney, J | 1 |
| Koumenis, I | 1 |
| Shahrokh, Z | 1 |
| McKay, P | 1 |
| Galan, W | 1 |
| Wagner, B | 1 |
| Narindray, D | 1 |
| Hébert, C | 1 |
| Zapata, G | 1 |
10 other studies available for alanine and Anasarca
| Article | Year |
|---|---|
Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies.
Topics: Alanine; Animals; Biological Availability; Biological Products; Carrageenan; Chemical Engineering; C | 2021 |
A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs.
Topics: Adenine; Alanine; Animals; Anti-HIV Agents; Dogs; Edema; HIV Infections; HIV-1; Infusions, Subcutane | 2021 |
Solomonamides A and B, new anti-inflammatory peptides from Theonella swinhoei.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Edema; | 2011 |
Pharmacological activity of a Bv8 analogue modified in position 24.
Topics: Alanine; Amino Acid Substitution; Amphibian Proteins; Analgesics; Animals; Chemotaxis; CHO Cells; Cr | 2012 |
Supplementation with aromatic amino acids improves leucine kinetics but not aromatic amino acid kinetics in infants with infection, severe malnutrition, and edema.
Topics: Alanine; Amino Acids, Aromatic; Anthropometry; Body Water; Deuterium; Edema; Enteral Nutrition; Huma | 2004 |
Response properties of dorsal root reflexes in cutaneous C fibers before and after intradermal capsaicin injection in rats.
Topics: Action Potentials; Alanine; Animals; Capsaicin; Drug Interactions; Edema; Extremities; GABA Plasma M | 2005 |
Biocompatibility of elastin-like polymer poly(VPAVG) microparticles: in vitro and in vivo studies.
Topics: Alanine; Amino Acid Sequence; Animals; Biocompatible Materials; Cell Survival; Conjunctivitis; Edema | 2006 |
Potential anti-inflammatory actions of the elmiric (lipoamino) acids.
Topics: Alanine; Animals; Anti-Inflammatory Agents; Cell Line; Cell Proliferation; Chromatography, Thin Laye | 2007 |
Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs.
Topics: Adrenocorticotropic Hormone; Alanine; Animals; Cells, Cultured; Corticotropin-Releasing Hormone; Ede | 1994 |
Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation.
Topics: Alanine; Animals; Antibodies, Monoclonal; Antigen-Antibody Reactions; DNA, Complementary; Edema; Ele | 2001 |